Comparison of Enoxaparin and Warfarin for Secondary Prevention of Cancer-Associated Stroke

Background. The aim of this study was to determine which anticoagulant is superior for secondary prevention of cancer-associated stroke, using changes in D-dimer levels as a biomarker for recurrent thromboembolic events. Methods. We conducted a retrospective, single center observational study includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Hyemin, Lee, Jung Jae, Lee, Mi Ji, Ryoo, Sookyung, Yoon, Chang Hyo, Kim, Gyeong-Moon, Chung, Chin-Sang, Lee, Kwang Ho, Bang, Oh Young, Kim, Suk Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439482/
https://www.ncbi.nlm.nih.gov/pubmed/26064116
http://dx.doi.org/10.1155/2015/502089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439482/
https://www.ncbi.nlm.nih.gov/pubmed/26064116
http://dx.doi.org/10.1155/2015/502089

Ejemplares similares